Efficacy of Pharmacological Stimulation of Brown and White Fat in Lean and Obese Young Adults
Phase of Trial: Phase II
Latest Information Update: 13 May 2017
At a glance
- Drugs Mirabegron (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Acronyms MiraBAT
- 08 May 2017 Planned End Date changed from 1 Dec 2017 to 1 Mar 2018.
- 08 May 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Oct 2017.
- 08 May 2017 Status changed from not yet recruiting to recruiting.